1. 778TiPIpilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): The randomized phase II INTEGA trial (AIO STO 0217). (23rd October 2018) Authors: Goekkurt, E; Binder, M; Lorenzen, S; Thuss-Patience, P C; Al-Batran, S-E; Hinke, A; Hegewisch-Becker, S; Nilsson, S; Bokemeyer, C; Stein, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis. Issue 2 (22nd August 2011) Authors: Binder, M; Uhl, M; Wiech, T; Kollert, F; Thiel, J; Sass, J O; Walker, U A; Peter, H H; Warnatz, K Journal: Annals of the rheumatic diseases Issue: Volume 71:Issue 2(2012) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P06.01 ROR1-CAR T-cells as novel treatment strategy for anaplastic thyroid carcinoma. (21st September 2022) Authors: Chernyakov, D; Skorobohatko, O; Edemir, B; Nerger, K; Müller, T; Binder, M; Trojanowicz, B; Lorenz, K; Hüttelmaier, S; Alb, M; Hudecek, M; Dierks, C Journal: Journal for immunotherapy of cancer Issue: Volume 10(2022)Supplement 1 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗